Webinar
30.03.2026
Most Favoured Nation (MFN) Policy: Latest Developm...

This on-demand session provides a concise update on recent developments in Most Favoured Nation (MFN...

Read more
Articles
28.01.2026
If You’re a Market Access Lead in 2026: How to N...

In 2026, U.S. policy shifts will link domestic US prices to internatio...

Read more
Articles
01.10.2025
MFN Drug Pricing Proposal: What It Could Mean for ...

Negotiations between the Trump administration and pharmaceutical companies on lowering U.S...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch